ScholarLens Back to search
2007•The Journal of Clinical PsychiatryOpen access

Aripiprazole-Induced Psychosis

Nestor D. Kapusta, Nilufar Mossaheb, Christian Barnas, Peter Fischer

Open full text 6 citations

Abstract

Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Aripiprazole is a new atypical antipsychotic with a partial agonist activity at D2 and 5-HT1A receptors and with potent 5-HT2A receptor antagonism. Dose titration is considered necessary by some authors,1 but not by others.2,3 Recently, multiple cases of worsening of psychotic symptoms after add-on treatment with aripiprazole have been reported.4-8

Open-access reader

About this research paper

What this paper is about

Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Aripiprazole is a new atypical antipsychotic with a partial agonist activity at D2 and 5-HT1A receptors and with potent 5-HT2A receptor antagonism. Dose titration is considered necessary by some authors,1 but not by others.2,3 Recently, multiple cases of worsening of psychotic symptoms after add-on treatment with aripiprazole have been reported.4-8

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Article AbstractBecause this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.Sir: Aripiprazole is a new atypical antipsychotic with a partial agonist activity at D2 and 5-HT1A receptors and with potent 5-HT2A receptor antagonism. Dose titration is considered necessary by some authors,1 but not by others.2,3 Recently, multiple cases of worsening of psychotic symptoms after add-on treatment with aripiprazole have been reported.4-8

Key concepts: Aripiprazole, Partial agonist, Psychosis, Antipsychotic, Agonist, Psychology, Psychiatry, Atypical antipsychotic

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Aripiprazole-Induced Psychosis — Research Paper | ScholarLens